Actinogen announces new and unique nonproprietary name of ’emestedastat’ for Xanamem
Hand-out
Press Releases
February 5, 2025

Actinogen announces new and unique nonproprietary name of ’emestedastat’ for Xanamem

Late-stage Alzheimer's trial opens 10 new sites in USA, with results due in 2025 and 2026

bradford

The Bradford Era

Local & Social